Ultragenyx (RARE) awards RSUs and 79,936 stock options to officer
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Ultragenyx Pharmaceutical Inc. reported that officer Dennis Karl Huang received equity awards consisting of common stock and stock options. He was granted 23,116 shares of common stock as Restricted Stock Units (RSUs), bringing his direct common stock holdings to 147,845 shares after the award.
The RSUs were granted under the company’s 2023 Incentive Plan and vest in four equal annual installments on each anniversary of the grant date. Huang was also granted 79,936 stock options with an exercise price of $24.52 per share, expiring on April 16, 2036, which vest over four years with 1/4 vesting after one year and the remainder vesting monthly.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Huang Dennis Karl
Role
See Remarks
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 79,936 | $0.00 | -- |
| Grant/Award | Common Stock | 23,116 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 79,936 shares (Direct, null);
Common Stock — 147,845 shares (Direct, null)
Footnotes (1)
- Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.
Key Figures
RSU grant: 23,116 shares
Common shares after grant: 147,845 shares
Stock option grant: 79,936 options
+4 more
7 metrics
RSU grant
23,116 shares
Restricted Stock Units granted on April 16, 2026
Common shares after grant
147,845 shares
Direct common stock holdings following RSU award
Stock option grant
79,936 options
Stock options granted on April 16, 2026
Option exercise price
$24.52 per share
Exercise price for 79,936 stock options
Option expiration
April 16, 2036
Expiration date of granted stock options
RSU vesting schedule
4 annual installments
1/4 of RSUs vest each year over four years
Option vesting schedule
1/4 after 1 year, then monthly
1/4 vests at first anniversary; 1/48 monthly thereafter
Key Terms
Restricted Stock Units ("RSUs"), 2023 Incentive Plan, Stock Option (Right to Buy), vesting conditions, +1 more
5 terms
Restricted Stock Units ("RSUs") financial
"Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
2023 Incentive Plan financial
"Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan."
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with underlying security title Common Stock."
vesting conditions financial
"shares of common stock underlying RSUs ... are subject to certain vesting conditions."
Vesting conditions are the rules that determine when someone earning company stock or stock options actually gains the right to keep or sell them, typically based on staying with the company for a set time or meeting performance targets. Think of it like keys that unlock gradually — some unlock by calendar date, others only after agreed milestones. Investors care because vesting shapes management incentives, the timing of share sales, and the number of shares that can enter the market, which can affect a company's valuation and ownership mix.
exercise price financial
"conversion_or_exercise_price: 24.5200 per underlying share of Common Stock."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What equity awards did Dennis Karl Huang receive from Ultragenyx (RARE)?
Dennis Karl Huang received 23,116 Restricted Stock Units and 79,936 stock options. The RSUs are common stock awards, while the options give him the right to buy common shares at a fixed exercise price over a long-term vesting schedule.
How do the new RSUs granted to Dennis Karl Huang at Ultragenyx (RARE) vest?
The 23,116 RSUs vest in four equal annual installments. One quarter of the underlying common shares vests on each anniversary of the grant date, so the award becomes fully vested on the fourth anniversary if vesting conditions continue to be satisfied.
What are the key terms of Dennis Karl Huang’s new Ultragenyx (RARE) stock options?
Huang received 79,936 stock options with a $24.52 exercise price per share. One quarter vests on the first anniversary of the grant, and the remaining three quarters vest in equal monthly installments, with the options expiring on April 16, 2036 if not exercised earlier.
Are Dennis Karl Huang’s new Ultragenyx (RARE) awards open-market purchases or compensation grants?
These transactions are compensation-related grants, not open-market trades. Both the RSUs and stock options were awarded under Ultragenyx’s 2023 Incentive Plan, with a transaction code indicating grant or award acquisition rather than a discretionary market purchase or sale.